title: An electrocardiograph should be examined in patients with a hypersensitive esophagus before a trial of citalopram.
authors: Tae Hee
authors: TH
authors: Lee
authors: Joon Seong
authors: JS
authors: Lee
mesh_terms: D015415:Biomarkers / Q000097:blood; D015283:Citalopram / Q000008:administration & dosage / Q000009:adverse effects*; D018849:Controlled Clinical Trials as Topic; D004562:Electrocardiography; D004947:Esophagus / Q000503:physiopathology*; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications*; D008274:Magnesium / Q000097:blood; D011188:Potassium / Q000097:blood; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000139:chemically induced*
chemical_list: D015415:Biomarkers; D015283:Citalopram; D008274:Magnesium; D011188:Potassium; D054328:Proton Pump Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors